Plymouth Meeting, Pa. — November 18, 2025 — Leads & Copy — Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) will participate in several upcoming investor conferences, the company announced today.
Harmony’s management team is scheduled to appear at:
- Citi’s 2025 Global Healthcare Conference in Miami, FL, on Tuesday, December 2, 2025.
- The 8th Annual Evercore Healthcare Conference in Miami, FL. A fireside chat is scheduled for Tuesday, December 2, 2025, at 2:35 p.m. ET.
- The Piper Sandler 37th Annual Healthcare Conference in New York, NY. A fireside chat is scheduled for Wednesday, December 3, 2025, at 10:30 a.m. ET.
Webcasts of the fireside chats will be available on the investor page of Harmony Biosciences’ website.
Harmony Biosciences is a pharmaceutical company focused on developing and commercializing therapies for patients with rare neurological diseases. The company was established by Paragon Biosciences, LLC, in 2017 and is headquartered in Plymouth Meeting, Pa.
Harmony Biosciences aims to nurture a future full of therapeutic possibilities that may enable patients with rare neurological diseases to truly thrive. The company believes that when empathy and innovation meet, a better future can begin.
For more information, please visit www.harmonybiosciences.com.
Source: Harmony Biosciences
